2018 Late Phase Study Trends and Market Outlook

Late Phase Market Outlook: 2018-2022

$4,460.00 – $8,920.00

Licensing Options

  • SINGLE-USER LICENSE

    A Single-User License allows access to an individual user.

  • SITE-WIDE LICENSE (not available for all reports)

    A Site-Wide License allows access to an organization's employees within a single site/location (e.g. New York City office).

  • ENTERPRISE-WIDE LICENSE

    An Enterprise-Wide License allows access to all employees and sites within an organization.

Related products

  • Select options This product has multiple variants. The options may be chosen on the product page

    Late Phase Market Overview and Outlook (2013)

    $4,900.00 – $9,800.00
  • Select options This product has multiple variants. The options may be chosen on the product page

    Adaptive Trial Market Dynamics

    $2,460.00 – $4,920.00
  • Select options This product has multiple variants. The options may be chosen on the product page

    Improving Patient Recruitment in Biosimilar Trials

    $3,260.00 – $6,520.00
  • Select options This product has multiple variants. The options may be chosen on the product page

    CRO Quality Benchmarking – Phase IV Service Providers (4th edition)

    $4,900.00 – $9,800.00